n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems

Biochemical Journal

Volumn 411, Issue 1, 2008, Pages 97-105

  Kimura, Motohide ^a   Takabuchi, Satoshi ^a,b   Tanaka, Tomoharu ^b   Murata, Miyahiko ^c   Nishi, Kenichiro ^a,d   Oda, Seiko ^a,b   Oda, Tomoyuki ^c   Kanai, Michiyuki ^a   Fukuda, Kazuhiko ^b   Kizaka Kondoh, Shinae ^e   Adachi, Takehiko ^a   Takabayashi, Arimichi ^a   Semenza, Gregg L ^f   Hirota, Kiichi ^a,b  

^a Kitano Hospital   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Erythropoietin; Hypoxia inducible factor 1 (HIF 1 ) hydroxylase; Intestinal trefoil factor; Vascular endothelial growth factor (VEGF)

Indexed keywords

ERYTHROPOIETIN; HYPOXIA-INDUCIBLE FACTOR HYDROXYLASE; INTESTINAL TREFOIL FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

CELL CULTURE; OXYGEN SENSORS; RATS; TOXIC MATERIALS; TRANSCRIPTION;

ENZYME ACTIVITY;

ASPARAGINE HYPOXIA INDUCIBLE FACTOR 1 ALPHA HYDROXYLASE; GALLIC ACID PROPYL ESTER; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; OXYGENASE; PROLINE HYPOXIA INDUCIBLE FACTOR 1 ALPHA HYDROXYLASE; PROTEIN P300; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ANGIOGENESIS; ARTICLE; EMBRYO; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; OXYGEN SENSING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MICE; OXYGEN; P300-CBP TRANSCRIPTION FACTORS; PROPYL GALLATE; TRANSFECTION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

LOTUS; MUS;

EID: 41649116838     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20070824     Document Type: Article

References (45)

1. Semenza, G. L. (2000) HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983-1991
2. Giaccia, A., Siim, B. and Johnson, R. (2003) HIF-1 as a target for drug development. Nat. Rev. Drug. Discov. 2, 803-811
3. Pugh, C. and Ratcliffe, P. (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677-684
4. Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T. and De Bruijn, E. A. (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56, 549-580
5. 2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510-5514
6. 2 sensing. Science 292, 464-468
7. 2-regulated prolyl hydroxylation. Science 292, 468-472
8. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A. et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54
9. Bruick, R. and McKnight, S. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340
10. Mahon, P. C., Hirota, K. and Semenza, G. L. (2001) FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686
11. Lando, D., Peet, D. J. Gorman, J. J., Whelan, D. A., Whitelaw, M. L. and Bruick, R. K. (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471
12. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C. and Semenza, G. L. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995-4004
13. Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M. and Semenza, G. L. (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205-38211
14. Page, E. L., Robitaille, G. A., Pouyssegur, J. and Richard, D. E. (2002) Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J. Biol. Chem. 277, 48403-48409
15. Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L. and Hirota, K. (2004) Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling. J. Biol. Chem. 279, 2550-2558
16. Bergeron, M., Gidday, J. M., Yu, A. Y., Semenza, G. L., Ferriero, D. M. and Sharp, F. R. (2000) Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann. Neurol. 48, 285-296
17. Patel, T. H., Kimura, H., Weiss, C. R., Semenza, G. L. and Hofmann, L. V. (2005) Constitutively active HIF-1α improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc. Res. 68, 144-154
18. Ema, M., Hirota, K., Mimura, J., Abe, H., Yodoi, J., Sogawa, K., Poellinger, L. and Fujii-Kuriyama, Y. (1999) Molecular mechanisms of transcription activation by HLF and HIF-1α in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18, 1905-1914
19. Liu, Q., Berchner-Pfannschmidt, U., Moller, U., Brecht, M., Wotzlaw, C., Acker, H., Jungermann, K. and Kietzmann, T. (2004) A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc. Natl. Acad. Sci. U.S.A. 101, 4302-4307
20. Semenza, G. L., Jiang, B. H., Leung, S. W., Passantino, R., Concordet, J. P., Maire, P. and Giallongo, A. (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271, 32529-32537
21. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. and Semenza, G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613
22. Jiang, B. H., Zheng, J. Z., Leung, S. W., Roe, R. and Semenza, G. L. (1997) Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272, 19253-19260
23. Nagai, T., Ibata, K., Park, E., Kubota, M., Mikoshiba, K. and Miyawaki, A. (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20, 87-90
24. Harada, H., Hiraoka, M. and Kizaka-Kondoh, S. (2002) Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells. Cancer Res. 62, 2013-2018
25. Ang, S. O., Chen, H., Hirota, K., Gordeuk, V. R., Jelinek, J. Guan, Y., Liu, E., Sergueeva, A. I., Miasnikova, G. Y., Mole, D. et al. (2002) Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat. Genet. 32, 614-621
26. Itoh, T., Namba, T., Fukuda, K., Semenza, G. L. and Hirota, K. (2001) Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane. FEBS Lett. 509, 225-229
27. Hirota, K. and Semenza, G. L. (2001) Rac1 activity is required for the activation of hypoxia-inducible factor 1. J. Biol. Chem. 276, 21166-21172
28. Wang, G. L. and Semenza, G. L. (1993) Desferoxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82, 3610-3615
29. 2 insult. Exp. Eye Res. 76, 49-59
30. Kawanishi, S., Oikawa, S. and Murata, M. (2005) Evaluation for safety of antioxidant chemopreventive agents. Antioxid. Redox Signal. 7, 1728-1739
31. Cai, Z., Manalo, D. J., Wei, G., Rodriguez, E. R., Fox-Talbot, K., Lu, H., Zweier, J. L. and Semenza, G. L. (2003) Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108, 79-85
32. Mole, D. R., Schlemminger, I., McNeill, L. A., Hewitson, K. S., Pugh, C. W., Ratcliffe, P. J. and Schofield, C. J. (2003) 2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. Bioorg. Med. Chem. Lett. 13, 2677-2680
33. McDonough, M. A., McNeill, L. A., Tilliet, M., Papamicael, C. A., Chen, Q. Y. Banerji, B., Hewitson, K. S. and Schofield, C. J. (2005) Selective inhibition of factor inhibiting hypoxia-inducible factor. J. Am. Chem. Soc. 127, 7680-7681
34. 2 is mediated by hypoxia-inducible factor 1. Cancer Res. 63, 2330-2334
35. Zhou, J., Callapina, M., Goodall, G. J. and Brüne, B. (2004) Functional integrity of nuclear factor ArB, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase signaling allows tumor necrosis factor α-evoked Bcl-2 expression to provoke internal ribosome entry site-dependent translation of hypoxia-inducible factor 1α. Cancer Res. 64, 9041-9048
36. Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J. and Whitelaw, M. L. (2002) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858-861
37. Zhou, Y., Kim, Y., Li, X., Baerson, S., Agarwal, A., Hodges, T., Ferreira, D. and Nagle, D. (2004) Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. J. Nat. Prod. 67, 2063-2069
38. Thomas, R. and Kim, M. H. (2005) Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells. Biochem. Biophys. Res. Commun. 334, 543-548
39. Tsukiyama, F., Nakai, Y., Yoshida, M., Tokuhara, T., Hirota, K., Sakai, A., Hayashi, H. and Katsumata, T. (2006) Gallate, the component of HIF-inducing catechins, inhibits HIF prolyl hydroxylase. Biochem. Biophys. Res. Commun. 351, 234-239
40. Bruick, R. and McKnight, S. (2001) Building better vasculature. Genes Dev. 15, 2497-2502
41. Kelly, B., Hacked, S. F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P. A. and Semenza, G. L. (2003) Cell-type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in non-ischemic tissue by a constitutively-active form of hypoxia-inducible factor 1. Circ. Res. 93, 1074-1081
42. Bernaudin, M., Nedelec, A., Divoux, D., MacKenzie, E., Petit, E. and Schumann-Bard, P. (2002) Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22, 393-403
43. Taupin, D. and Podolsky, D. K. (2003) Trefoil factors: initiators of mucosal healing. Nat. Rev. Mol. Cell Biol. 4, 721-732
44. Baker, J. E. (2005) Erythropoietin mimics ischemic preconditioning. Vascul. Pharmacol. 42, 233-241
45. Malese, K., Li, F. and Chong, Z. Z. (2005) New avenues of exploration for erythropoietin. JAMA, J. Am. Med. Assoc. 293, 90-95